Search research articles
Contact Us
Filters
Showing results (81-90 of 89) with videos related to
Page
of 9
Sort By:
You have reached the last page of results.
This site can display upto 89 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 19, 2006
Temozolomide in combination with celecoxib in patients with advanced melanoma. A phase II study of the Hellenic Cooperative Oncology Group
H Gogas, A Polyzos, I Stavrinidis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 7, 2002
Neoadjuvant chemotherapy with a combination of pegylated liposomal doxorubicin (Caelyx) and paclitaxel in locally advanced breast cancer: a phase II study by the Hellenic Cooperative Oncology Group
H Gogas, C Papadimitriou, H P Kalofonos, et al.
British Journal of Cancer
|
October 15, 2014
Time dependence of biomarkers: non-proportional effects of immunohistochemical panels predicting relapse risk in early breast cancer
J Stephen, G Murray, D A Cameron, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 10, 2018
Impact of age on breast cancer mortality and competing causes of death at 10 years follow-up in the adjuvant TEAM trial
M G M Derks, E Bastiaannet, W van de Water, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 9, 2005
Postoperative dose-dense sequential chemotherapy with epirubicin, followed by CMF with or without paclitaxel, in patients with high-risk operable breast cancer: a randomized phase III study conducted by the Hellenic Cooperative Oncology Group
G Fountzilas, D Skarlos, U Dafni, et al.
British Journal of Cancer
|
October 5, 2013
Do type 1 receptor tyrosine kinases inform treatment choice? A prospectively planned analysis of the TEAM trial
J M S Bartlett, C L Brookes, T Piper, et al.
The British Journal of Surgery
|
April 16, 2010
Variations in locoregional therapy in postmenopausal patients with early breast cancer treated in different countries
J G H van Nes, C Seynaeve, S Jones, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 29, 2007
Postoperative dose-dense sequential chemotherapy with epirubicin, paclitaxel and CMF in patients with high-risk breast cancer: safety analysis of the Hellenic Cooperative Oncology Group randomized phase III trial HE 10/00
G Fountzilas, U Dafni, H Gogas, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 19, 2015
Adjuvant bisphosphonates in early breast cancer: consensus guidance for clinical practice from a European Panel
P Hadji, R E Coleman, C Wilson, et al.
Page
of 9
Search research articles
Search
Showing results (81-90 of 89) with videos related to
Sort By:
Page
of 9
You have reached the last page of results.
This site can display upto 89 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 19, 2006
Temozolomide in combination with celecoxib in patients with advanced melanoma. A phase II study of the Hellenic Cooperative Oncology Group
H Gogas, A Polyzos, I Stavrinidis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 7, 2002
Neoadjuvant chemotherapy with a combination of pegylated liposomal doxorubicin (Caelyx) and paclitaxel in locally advanced breast cancer: a phase II study by the Hellenic Cooperative Oncology Group
H Gogas, C Papadimitriou, H P Kalofonos, et al.
British Journal of Cancer
|
October 15, 2014
Time dependence of biomarkers: non-proportional effects of immunohistochemical panels predicting relapse risk in early breast cancer
J Stephen, G Murray, D A Cameron, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 10, 2018
Impact of age on breast cancer mortality and competing causes of death at 10 years follow-up in the adjuvant TEAM trial
M G M Derks, E Bastiaannet, W van de Water, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 9, 2005
Postoperative dose-dense sequential chemotherapy with epirubicin, followed by CMF with or without paclitaxel, in patients with high-risk operable breast cancer: a randomized phase III study conducted by the Hellenic Cooperative Oncology Group
G Fountzilas, D Skarlos, U Dafni, et al.
British Journal of Cancer
|
October 5, 2013
Do type 1 receptor tyrosine kinases inform treatment choice? A prospectively planned analysis of the TEAM trial
J M S Bartlett, C L Brookes, T Piper, et al.
The British Journal of Surgery
|
April 16, 2010
Variations in locoregional therapy in postmenopausal patients with early breast cancer treated in different countries
J G H van Nes, C Seynaeve, S Jones, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 29, 2007
Postoperative dose-dense sequential chemotherapy with epirubicin, paclitaxel and CMF in patients with high-risk breast cancer: safety analysis of the Hellenic Cooperative Oncology Group randomized phase III trial HE 10/00
G Fountzilas, U Dafni, H Gogas, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 19, 2015
Adjuvant bisphosphonates in early breast cancer: consensus guidance for clinical practice from a European Panel
P Hadji, R E Coleman, C Wilson, et al.
Page
of 9